We had been on the trajectory for a rather uneventful day, upended temporarily by no real news but that which send market indexes into the red. The Nasdaq and S&P 500 bounced back and finished in the ...

Fortune Brands Innovations expects full-year earnings in the range of $4.15 to $4.45 per share. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks ...

A-Mark Precious Metals (AMRK) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.90 per share a year ago.

For the current quarter ending in March, Onto Innovation expects its per-share earnings to range from $1.40 to $1.54. The company said it expects revenue in the range of $260 million to $274 million ...

ST. LOUIS (AP) — ST. LOUIS (AP) — Post Holdings Inc. (POST) on Thursday reported fiscal first-quarter earnings of $113.3 million. The St. Louis-based company said it had profit of $1.78 per share.

The Carmel, Indiana-based company said it had net income of $1.58 per share. Earnings, adjusted for non-recurring gains, came to $1.31 per share. The results topped Wall Street expectations. The ...

Today's Research Daily features the Q4 earnings season scorecard and updated analyst reports on 16 major stocks, including Meta Platforms, Mastercard and Adobe, as well as two micro-cap stocks ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

For the current quarter ending in March, Linde expects its per-share earnings to range from $3.85 to $3.95. The company expects full-year earnings in the range of $16.15 to $16.55 per share.

Roblox Corp. (RBLX) on Thursday reported a loss of $219.6 million in its fourth quarter. On a per-share basis, the San ...

Stock analysts at Zacks Research cut their FY2024 earnings estimates for shares of American Financial Group in a research note issued to investors on Monday, February 3rd. Zacks Research analyst T. De ...

Equities research analysts at Zacks Small Cap cut their FY2025 earnings per share estimates for shares of Protalix BioTherapeutics in a report released on Monday, February 3rd. Zacks Small Cap analyst ...